[Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody].
Campana
C
C
Dipartimento di Cardiologia, Policlinico S. Matteo, IRCCS, Pavia.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015375:Receptors, Interleukin-2 / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D000077561:Daclizumab
Prevenzione del rigetto dopo trapianto cardiaco mediante il blocco del recettore dell'interleuchina-2 con un anticorpo monoclonale.